Julie E. Buring
 | The topic of this article may not meet Wikitia's general notability guideline. |
Julie E. Buring | |
|---|---|
| Add a Photo | |
| Alma mater |
|
| Occupation |
|
Julie Elizabeth Buring is an epidemiologist and professor at the Harvard T.H. Chan School of Public Health. Burnt is also a professor at the Boston University School of Public Health.[1]
Biography
Education
- Harvard University, ScD Field of Study: Epidemiology
- University of Washington, MS Field of Study: Biostatistics
- Pomona College, BA Field of Study: Mathematics
Awards
She has been recognized as an educator, scientist, writer, and doctor. In 2022 from the webpage, Research, she got the Best Scientist and Best Female Scientist awards.[2] From Pomona College, she received an honorary doctorate degree. From the Harvard School of Public Health, she received the Roger L. Nichols Excellence in Teaching Award. As well as from American Public Health Association, and she received the John Snow Award, Epidemiology Section award.[3]
Publications
Julie has been involved in over 80 publications. All of them are related to her work and clinical trials. Some of her more well-known works are Women In Clinical Trials-A Portfolio for Success and her findings on low-dose aspirin and its effects in cases that involve women’s cardiovascular problems.
Career
Buring works with Harvard Medical School and Brigham and Women's Hospital. She is a professor in the epidemiology department at Harvard and a medicine professor. She teaches and directs the course EPI 200: Principles of Epidemiology.[3] In all her clinical trials, she also serves as a principal investigator. She is the chair of the Institutional Review Board of Harvard Medical School. She works with students nationally and internationally to train students about the epidemiology of cardiovascular disease.[4], [5]
Clinical trials
The prime focus of her research it's the prevention of cardiovascular disease and cancers. She connects risk factors like stroke and blood pressure into her investigation of cardiology. Two of her most famous clinical trials are a randomized trial of low-dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer, along with the use of vitamin D in the prevention of cardiovascular disease and cancer.[6] In her first study with vitamin E, there was over 40,000 participants.[3] In her vitamin D study, there were over 25,000 participants. All her trials have in common the prevention of cardiovascular disease and cancers in women specifically. She was involved in designing, analyzing, and practicing these large clinical trials[7]
References
- ↑ "Julie E. Buring, ScD". Boston University School of Public Health. Retrieved 28 April 2023.
- ↑ "Julie E. Buring: H-index & Awards - Academic Profile". Research.com. Retrieved 2023-04-17.
- ↑ 3.0 3.1 3.2 "Julie E. Buring". Harvard School of Public Health. Retrieved 28 April 2023.
- ↑ "Julie Buring – Society for Epidemiologic Research". Retrieved 2023-04-17.
- ↑ "Julie Buring, ScD". Boston University. Retrieved 29 April 2023.
- ↑ Buring, Julie E. (2012-06-12). "Women's Health Study of Low-dose Aspirin and Vitamin E in Apparently Healthy Women". Brigham and Women's Hospital, National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI).
{{cite journal}}: Cite journal requires|journal=(help) - ↑ "Julie Buring – Society for Epidemiologic Research". Retrieved 2023-04-17.
External links
This article "Julie E. Buring" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.